Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Oct 14;16(20):3480.
doi: 10.3390/nu16203480.

Positive Effects of Aerobic-Resistance Exercise and an Ad Libitum High-Protein, Low-Glycemic Index Diet on Irisin, Omentin, and Dyslipidemia in Men with Abdominal Obesity: A Randomized Controlled Trial

Affiliations
Randomized Controlled Trial

Positive Effects of Aerobic-Resistance Exercise and an Ad Libitum High-Protein, Low-Glycemic Index Diet on Irisin, Omentin, and Dyslipidemia in Men with Abdominal Obesity: A Randomized Controlled Trial

Agnieszka Suder et al. Nutrients. .

Abstract

Objectives: The aim of this research was to evaluate changes in body composition, adipokine levels, and dyslipidemia parameters in males with abdominal obesity following two distinct interventions: exercise alone and exercise combined with an ad libitum diet.

Methods: This study included 44 males with abdominal obesity (mean age 34.7 ± 5.5 years, waist circumference [WC] 110.3 ± 8.5, BMI 32.0 ± 3.9), who were randomly assigned to three groups: an experimental group engaging in aerobic-resistance exercise (II, n = 16), an experimental group engaging in aerobic-resistance exercise combined with an ad libitum high-protein, low-glycemic index carbohydrate diet (III, n = 16), both interventions lasting 6 weeks, and a control group without interventions (I, n = 12). Body composition metrics (body mass index [BMI], waist circumference [WC], body fat [BF], abdominal fat [ABD]) and fat-free mass [FFM], along with biochemical blood analyses (irisin [IR], omentin [OMEN], glucose [GLU], insulin [INS], LDL- and HDL-cholesterol), were measured at baseline and after the 6-week intervention. The effects of the interventions on the analyzed variables across groups were assessed using mixed ANOVA tests with post-hoc comparisons. Effect size (ES) was also calculated using partial eta squared (ηp2).

Results: The intervention in group III resulted in a significant decrease in IR (p < 0.01, ηp2 = 0.03) by 41% and LDL-C (p < 0.01, ηp2 = 0.02) by 14%. These effects were associated with a reduction in BF (p < 0.01, ηp2 = 0.02) by 14%, ABD (p < 0.01, ηp2 = 0.03) by 31%, and WC (p < 0.01, ηp2 = 0.01) by 3%. In group II, decreases after 6 weeks of intervention were noted only in WC (p = 0.02, ηp2 = 0.01) by 1% and in INS (p < 0.01, ηp2 = 0.04) by 47%. No differences were found between groups. The use of low-glycemic index carbohydrates (p < 0.01, ηp2 = 0.06) and increased protein intake (p < 0.01, ηp2 = 0.30) led to changes in the fiber-to-energy value of the diet ratio (p < 0.01, ηp2 = 0.18) and a reduction in dietary energy value (p < 0.01, ηp2 = 0.13) by 23%, resulting in a greater energy deficit than in the II group.

Conclusions: These findings highlight the effect of combining dietary and exercise interventions to achieve significant changes in body composition and metabolic parameters, even over a short period of intervention.

Keywords: abdominal obesity; aerobic-resistance exercise; body mass index; carbohydrates; fiber; irisin; low-glycemic index; omentin; protein intake.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. The funders had no role in the design of this study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Study flowchart.
Figure 2
Figure 2
Variation in irisin (IR) [ng/mL] concentration in the control (CG I), exercise (EG II), and exercise–diet (EGD III) groups at baseline and after six weeks.

References

    1. Blüher M. Obesity: Global epidemiology and pathogenesis. Nat. Rev. Endocrinol. 2019;15:288–298. doi: 10.1038/s41574-019-0176-8. - DOI - PubMed
    1. Kruschitz R., Fahrnberger M., Felsenreich D.M., Ress C., Andersen B., Aydinkoc-Tuzcu K., Ciardi C., Huber S.L., Kiefer F.W. Prevention and management of postinterventional weight regain. Wien. Klin. Wochenschr. 2023;135:743–750. doi: 10.1007/s00508-023-02273-6. - DOI - PMC - PubMed
    1. Schleh M.W., Caslin H.L., Garcia J.N., Mashayekhi M., Srivastava G., Bradley A.B., Hasty A.H. Metaflammation in obesity and its therapeutic targeting. Sci. Transl. Med. 2023;15:eadf9382. doi: 10.1126/scitranslmed.adf9382. - DOI - PMC - PubMed
    1. Suder A. Socioeconomic and lifestyle determinants of body fat distribution in young working males from Cracow, Poland. Am. J. Hum. Biol. 2007;20:100–109. doi: 10.1002/ajhb.20687. - DOI - PubMed
    1. Alexander L., Christensen S.M., Richardson L., Ingersoll A.B., Burridge K., Golden A., Karjoo S., Cortez D., Shelver M., Bays H.E. Nutrition and physical activity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022. Obes. Pillars. 2022;1:100005. doi: 10.1016/j.obpill.2021.100005. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources